Gilead Sciences logo

Gilead Sciences share price today

(GILD)

Gilead Sciences share price is $93.93 & ₹7,998.98 as on 25 Dec 2024, 2.30 'hrs' IST

$93.93

▲

0.53

(0.57%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Gilead Sciences share price in Dollar and Rupees. Guide to invest in Gilead Sciences from India. Also see the sentimental analysis on Indian investors investing in Gilead Sciences. Get details on the Indian mutual funds that are investing in Gilead Sciences. Get Analyst recommendations and forecasts along with all the Gilead Sciences's financials.

Gilead Sciences share price movements

  • Today's Low: $92.15
    Today's High: $94.00

    Day's Volatility :1.97%

  • 52 Weeks Low: $62.07
    52 Weeks High: $98.90

    52 Weeks Volatility :37.24%

Gilead Sciences Returns

PeriodGilead Sciences Inc.Sector (Health Care)Index (NASDAQ Composite)
3 Months
13.61%
-10.0%
9.4%
6 Months
34.76%
-5.7%
13.0%
1 Year
16.82%
2.8%
31.8%
3 Years
28.17%
-0.4%
26.3%

Gilead Sciences Key Statistics

in dollars & INR

Previous Close
$93.4
Open
$93.0
Today's High
$93.9976
Today's Low
$92.15
Market Capitalization
$115.4B
Today's Volume
$4.5M
52 Week High
$98.9
52 Week Low
$62.07
Revenue TTM
$28.3B
EBITDA
$13.9B
Earnings Per Share (EPS)
$0.09
PE Ratio
1028.56
Dividend Yield
3.33%
Profit Margin
0.45%
Quarterly Earnings Growth YOY
-0.42%
Return On Equity TTM
0.56%

How to invest in Gilead Sciences from India?

It is very easy for Indian residents to invest directly in Gilead Sciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gilead Sciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gilead Sciences or GILD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gilead Sciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gilead Sciences shares which would translate to 0.009 fractional shares of Gilead Sciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gilead Sciences, in just a few clicks!

Returns in Gilead Sciences for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gilead Sciences investment value today

Current value as on today

₹1,19,885

Returns

₹19,885

(+19.88%)

Returns from Gilead Sciences Stock

₹17,486 (+17.49%)

Dollar Returns

₹2,399 (+2.4%)

Indian investors sentiment towards Gilead Sciences

33%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Search volume for Gilead Sciences on INDmoney from India has grown in the last 30 days as on Dec 25, 2024. 33% more investors are searching Gilead Sciences in the last 30 days versus the previous period.

Global Institutional Holdings in Gilead Sciences

  • BlackRock Inc

    9.68%

  • Vanguard Group Inc

    9.26%

  • Capital World Investors

    6.14%

  • Capital Research Global Investors

    4.96%

  • State Street Corp

    4.83%

  • Wellington Management Company LLP

    2.78%

Analyst Recommendation on Gilead Sciences

Hold

    47%Buy

    52%Hold

    0%Sell

Based on 38 Wall street analysts offering stock ratings for Gilead Sciences(by analysts ranked 0 to 5 stars)

Based on 38 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
19
Hold
20
19
17
Sell
0
1
1

Analyst Forecast on Gilead Sciences

What analysts predicted

Upside of 5.31%

Current:

$93.93

Target:

$98.92

Insights on Gilead Sciences

  • Price Movement

    In the last 7 days, GILD stock has moved up by 0.6%

  • Increasing Revenue

    Gilead Sciences Inc. has shown a positive revenue trend over the last three quarters. Revenue increased from $6.68 billion to $7.54 billion, resulting in an average growth rate of 5.8% per quarter.

  • Decreasing Net Profit

    Gilead Sciences Inc. has experienced a decline in net profit over the last two quarters. In the most recent quarter, the net profit decreased from $1.61 billion to $1.25 billion. This represents an average decrease of 22.4% per quarter.

  • GILD vs LLY (1 yr)

    In the last 1 year, Eli Lilly And Company has given 39.6% return, outperforming this stock by 22.4%

  • GILD vs LLY (3 yr)

    In the last 3 years, Eli Lilly And Company has given 191.6% return, outperforming this stock by 162.7%

  • Price to Sales

    Gilead Sciences Inc. has a Price-to-Sales Ratio of 4.1, meaning that investors are willing to pay $4.1 for every $1 of sales generated by the company. In comparison, investors are willing to pay significantly more for Eli Lilly And Company, at $17.6 for every $1 of sales. This suggests that Gilead Sciences is viewed as less expensive relative to its sales than Eli Lilly.

Gilead Sciences Financials in INR & Dollars

FY18Y/Y Change
Revenue
$22.1B
↓ 15.24%
Net Income
$5.5B
↑ 17.87%
Net Profit Margin
24.65%
↑ 6.92%
FY19Y/Y Change
Revenue
$22.4B
↑ 1.46%
Net Income
$5.4B
↓ 1.26%
Net Profit Margin
23.99%
↓ 0.66%
FY20Y/Y Change
Revenue
$24.7B
↑ 9.98%
Net Income
$89.0M
↓ 98.35%
Net Profit Margin
0.36%
↓ 23.63%
FY21Y/Y Change
Revenue
$27.3B
↑ 10.6%
Net Income
$6.2B
↑ 6894.38%
Net Profit Margin
22.8%
↑ 22.44%
FY22Y/Y Change
Revenue
$27.3B
↓ 0.09%
Net Income
$4.6B
↓ 26.23%
Net Profit Margin
16.83%
↓ 5.97%
FY23Y/Y Change
Revenue
$27.1B
↓ 0.6%
Net Income
$5.7B
↑ 23.37%
Net Profit Margin
20.89%
↑ 4.06%
Q2 FY23Q/Q Change
Revenue
$6.6B
↑ 3.89%
Net Income
$1.0B
↑ 3.47%
Net Profit Margin
15.84%
↓ 0.06%
Q3 FY23Q/Q Change
Revenue
$7.1B
↑ 6.83%
Net Income
$2.2B
↑ 108.61%
Net Profit Margin
30.92%
↑ 15.08%
Q4 FY23Q/Q Change
Revenue
$7.1B
↑ 0.92%
Net Income
$1.4B
↓ 34.45%
Net Profit Margin
20.08%
↓ 10.84%
Q1 FY24Q/Q Change
Revenue
$6.7B
↓ 6.03%
Net Income
$-4.2B
↓ 391.81%
Net Profit Margin
-62.37%
↓ 82.45%
Q2 FY24Q/Q Change
Revenue
$6.9B
↑ 3.93%
Net Income
$1.6B
↓ 138.71%
Net Profit Margin
23.23%
↑ 85.6%
Q3 FY24Q/Q Change
Revenue
$7.5B
↑ 8.58%
Net Income
$1.3B
↓ 22.37%
Net Profit Margin
16.61%
↓ 6.62%
FY18Y/Y Change
Profit
$17.3B
↓ 20.53%
FY19Y/Y Change
Profit
$17.8B
↑ 2.89%
FY20Y/Y Change
Profit
$20.1B
↑ 13.18%
FY21Y/Y Change
Profit
$20.7B
↑ 2.92%
FY22Y/Y Change
Profit
$21.6B
↑ 4.44%
FY23Y/Y Change
Profit
$27.1B
↑ 25.4%
Q2 FY23Q/Q Change
Profit
$5.2B
↑ 4.16%
Q3 FY23Q/Q Change
Profit
$5.5B
↑ 6.36%
Q4 FY23Q/Q Change
Profit
$5.6B
↑ 1.28%
Q1 FY24Q/Q Change
Profit
$5.1B
↓ 7.58%
Q2 FY24Q/Q Change
Profit
$5.4B
↑ 5.28%
Q3 FY24Q/Q Change
Profit
$6.0B
↑ 10.47%
FY18Y/Y Change
Operating Cash Flow
$8.4B
↓ 29.4%
Investing Cash Flow
$14.4B
↓ 189.33%
Financing Cash Flow
$-12.3B
↓ 463.04%
FY19Y/Y Change
Operating Cash Flow
$9.1B
↑ 8.86%
Investing Cash Flow
$-7.8B
↓ 154.45%
Financing Cash Flow
$-7.6B
↓ 38.03%
FY20Y/Y Change
Operating Cash Flow
$8.2B
↓ 10.67%
Investing Cash Flow
$-14.6B
↑ 86.96%
Financing Cash Flow
$770.0M
↓ 110.09%
FY21Y/Y Change
Operating Cash Flow
$11.4B
↑ 39.37%
Investing Cash Flow
$-3.1B
↓ 78.58%
Financing Cash Flow
$-8.9B
↓ 1252.86%
FY22Y/Y Change
Operating Cash Flow
$9.1B
↓ 20.31%
Investing Cash Flow
$-2.5B
↓ 21.24%
Financing Cash Flow
$-6.5B
↓ 27.13%
FY23Y/Y Change
Operating Cash Flow
$8.0B
↓ 11.75%
Investing Cash Flow
$-2.3B
↓ 8.15%
Financing Cash Flow
$-5.1B
↓ 20.78%
Q2 FY23Q/Q Change
Operating Cash Flow
$2.3B
↑ 34.0%
Investing Cash Flow
$-483.0M
↓ 41.53%
Financing Cash Flow
$-1.1B
↓ 21.69%
Q3 FY23Q/Q Change
Operating Cash Flow
$1.8B
↓ 24.86%
Investing Cash Flow
$-229.0M
↓ 52.59%
Financing Cash Flow
$-1.5B
↑ 37.87%
Q4 FY23Q/Q Change
Operating Cash Flow
$2.2B
↑ 23.52%
Investing Cash Flow
$-727.0M
↑ 217.47%
Financing Cash Flow
$-1.1B
↓ 27.6%
Q1 FY24Q/Q Change
Operating Cash Flow
$2.2B
↑ 2.31%
Investing Cash Flow
$-2.2B
↑ 203.58%
Financing Cash Flow
$-1.4B
↑ 23.84%

Gilead Sciences Technicals Summary

Sell

Neutral

Buy

Gilead Sciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Gilead Sciences Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gilead Sciences Inc.
Gilead Sciences Inc.
3.22%
34.76%
16.82%
28.17%
41.62%
Eli Lilly And Company
Eli Lilly And Company
5.47%
-11.65%
39.53%
186.01%
505.44%
Johnson & Johnson
Johnson & Johnson
-6.75%
-1.06%
-6.96%
-14.38%
-0.33%
Merck & Co. Inc.
Merck & Co. Inc.
-1.77%
-24.43%
-7.67%
29.78%
8.6%
Novo Nordisk A/s
Novo Nordisk A/s
-15.16%
-38.25%
-13.61%
58.94%
204.53%
Abbvie Inc
Abbvie Inc
0.75%
4.23%
15.37%
32.72%
99.99%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gilead Sciences Inc.
Gilead Sciences Inc.
1028.56
1028.56
0.53
4.41
0.01
0.12
0.03
14.83
Eli Lilly And Company
Eli Lilly And Company
85.44
85.44
0.72
13.14
0.65
0.14
0.01
15.83
Johnson & Johnson
Johnson & Johnson
23.88
23.88
0.87
9.96
0.21
0.08
0.03
29.14
Merck & Co. Inc.
Merck & Co. Inc.
20.51
20.51
0.07
7.74
0.28
0.11
0.03
17.58
Novo Nordisk A/s
Novo Nordisk A/s
28.52
28.52
1.27
22.83
0.89
0.21
0.02
27.07
Abbvie Inc
Abbvie Inc
61.39
61.39
0.42
10.94
0.56
0.08
0.04
3.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gilead Sciences Inc.
Gilead Sciences Inc.
Hold
$115.4B
41.62%
1028.56
0.45%
Eli Lilly And Company
Eli Lilly And Company
Buy
$716.1B
505.44%
85.44
20.48%
Johnson & Johnson
Johnson & Johnson
Buy
$347.8B
-0.33%
23.88
16.74%
Merck & Co. Inc.
Merck & Co. Inc.
Buy
$248.0B
8.6%
20.51
19.23%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$363.6B
204.53%
28.52
35.01%
Abbvie Inc
Abbvie Inc
Buy
$310.3B
99.99%
61.39
9.22%

Gilead Sciences Dividend announcements

  • Gilead Sciences Dividends December, 2024

    In the quarter ending December,2024. Gilead Sciences has declared dividend of $0.77

    Read More

About Gilead Sciences

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Organization
Gilead Sciences
Employees
18000
CEO
Mr. Daniel P. O'Day
Industry
Health Technology

Management People of Gilead Sciences

NameTitle
Mr. Daniel P. O'Day
Chairman & CEO
Mr. Andrew D. Dickinson
Chief Financial Officer
Ms. Deborah H. Telman J.D.
Executive VP of Corporate Affairs, General Counsel & Corporate Secretary
Ms. Johanna Mercier
Chief Commercial Officer
Dr. Merdad V. Parsey M.D., Ph.D.
Chief Medical Officer
Ms. Sandra Patterson
Senior VP, Corporate Controller & Principal Accounting Officer
Ms. Jacquie Ross C.F.A.
Vice President of Investor Relations
Ms. Jyoti K. Mehra
Executive Vice President of Human Resources
Dr. Linda Slanec Higgins Ph.D.
Senior Vice President of Research, Innovation & Portfolio
Dr. Rudolf Ertl
Senior Vice President of Commercial Operations of Australia, Canada, Europe

Important FAQs about investing in Gilead Sciences from India :

What is Gilead Sciences share price today?

Gilead Sciences share price today stands at $93.93, Open: $93.00 ; Previous Close: $93.40 ; High: $94.00 ; Low: $92.15 ; 52 Week High: $98.90 ; 52 Week Low: $62.07. The stock opens at $93.00, after a previous close of $93.40. The stock reached a daily high of $94.00 and a low of $92.15, with a 52-week high of $98.90 and a 52-week low of $62.07.

Can Indians buy Gilead Sciences shares?

Yes, Indians can invest in the Gilead Sciences (GILD) from India.

With INDmoney, you can buy Gilead Sciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gilead Sciences at zero transaction cost.

How can I buy Gilead Sciences shares from India?

It is very easy to buy Gilead Sciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gilead Sciences be purchased?

Yes, you can buy fractional shares of Gilead Sciences with INDmoney app.

What are the documents required to start investing in Gilead Sciences stocks?

To start investing in Gilead Sciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gilead Sciences

Today’s highest price of Gilead Sciences (GILD) is $94.00.

Today’s lowest price of Gilead Sciences (GILD) is $92.15.

What is today's market capitalisation of Gilead Sciences

Today's market capitalisation of Gilead Sciences GILD is 115.4B

What is the 52 Week High and Low Range of Gilead Sciences

  • 52 Week High

    $98.90

  • 52 Week Low

    $62.07

What are the historical returns of Gilead Sciences?

  • 1 Month Returns

    3.22%

  • 3 Months Returns

    34.76%

  • 1 Year Returns

    16.82%

  • 5 Years Returns

    41.62%

Who is the Chief Executive Officer (CEO) of Gilead Sciences

Mr. Daniel P. O'Day is the current Chief Executive Officer (CEO) of Gilead Sciences.